Drug Profile
SB 001
Alternative Names: SB-001Latest Information Update: 25 Jun 2021
Price :
$50
*
At a glance
- Originator Solid Biosciences
- Class Antifibrotics
- Mechanism of Action Transforming growth factor beta inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Duchenne muscular dystrophy